In addition, anti-CD79b/CD3 TDB administration inhibited tumor growth in B cell lymphoma xenograft models and resulted in potent B cell depletion in the blood and spleens in a humanized murine model of lymphoma [18]. The gene discussed is CD79B; the disease is lymphoma.